In addition, when fucoxanthin, a xanthophyll present in brown seaweeds, was pharmacologically administrated in a breast cancer cell line, it suppressed PI3K/Akt signaling and NF-κB levels in a concentration-dependent manner, leading to inhibition of the malignant phenotype [168]. The gene discussed is NFKB1; the disease is breast cancer.